Commentary: Mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma

Environmental Health: A Global Access Science Source

Volumn 8, Issue 1, 2009, Pages

  Thompson, Chad M ^a   Grafström, Roland C ^b,c  

^a ToxStrategies Inc   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; DIMETHYLNITROSAMINE; FORMALDEHYDE; FORMALDEHYDE DEHYDROGENASE; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; S NITROSOGLUTATHIONE; S NITROSOGLUTATHIONE REDUCTASE; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; DNA DAMAGE; DRUG CYTOTOXICITY; EPSTEIN BARR VIRUS; HOMEOSTASIS; HYPERPLASIA; NASOPHARYNX CARCINOMA; OCCUPATIONAL EXPOSURE; REGENERATIVE ABILITY; RESPIRATORY FUNCTION; SIGNAL TRANSDUCTION; VIRUS CELL TRANSFORMATION; VIRUS LATENCY; VIRUS REACTIVATION; CARCINOMA; DRUG EFFECT; EPITHELIUM CELL; EPSTEIN BARR VIRUS INFECTION; EXPOSURE; HUMAN; NASOPHARYNX TUMOR; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4;

CARCINOMA; CELL TRANSFORMATION, VIRAL; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; FORMALDEHYDE; HERPESVIRUS 4, HUMAN; HUMANS; INHALATION EXPOSURE; NASOPHARYNGEAL NEOPLASMS; VIRUS ACTIVATION;

EID: 72849140626     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-8-53     Document Type: Article

References (76)

1. Occupational exposure to formaldehyde and wood dust and nasopharyngeal carcinoma. TL Vaughan PA Stewart K Teschke CF Lynch GM Swanson JL Lyon M Berwick, Occup Environ Med 2000 57 376 384 10810126
2. Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. A Hildesheim M Dosemeci CC Chan CJ Chen YJ Cheng MM Hsu IH Chen BF Mittl B Sun PH Levine, et al. Cancer Epidemiol Biomarkers Prev 2001 10 1145 1153 11700262
3. Mortality from solid cancers among workers in formaldehyde industries. M Hauptmann JH Lubin PA Stewart RB Hayes A Blair, Am J Epidemiol 2004 159 1117 1130 15191929
4. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol. IARC, Lyon: IARC 2006
5. The biology and pathology of selected skull base tumors. L Barnes SB Kapadia, J Neurooncol 1994 20 213 240 7844620
6. Genetic and epigenetic changes in nasopharyngeal carcinoma. KW Lo DP Huang, Semin Cancer Biol 2002 12 451 462 12450731
7. Nasopharyngeal carcinoma. AT Chan PM Teo PJ Johnson, Ann Oncol 2002 13 1007 1015 12176778
8. Epstein-Barr virus in the pathogenesis of NPC. N Raab-Traub, Semin Cancer Biol 2002 12 431 441 12450729
9. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1. D Nguyen-Van I Ernberg P Phan-Thi Phi C Tran-Thi L Hu, Virus Genes 2008 37 273 281 18663567
10. Proposed Cancer Mode of Action for Formaldehyde Based on EPA Cancer Guidelines. JE Whalan D DeVoney CM Thompson P White JJ Vandenberg, Annual Meeting of the Society of Toxicology: 2006; San Diego, CA 2006
11. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. WD Kerns KL Pavkov DJ Donofrio EJ Gralla JA Swenberg, Cancer Res 1983 43 4382 4392 6871871
12. Regional increases in rat nasal epithelial cell proliferation following acute and subchronic inhalation of formaldehyde. TM Monticello FJ Miller KT Morgan, Toxicol Appl Pharmacol 1991 111 409 421 1746023
13. Nasal tumours in rats after severe injury to the nasal mucosa and prolonged exposure to 10 ppm formaldehyde. RA Woutersen A van Garderen-Hoetmer JP Bruijntjes A Zwart VJ Feron, J Appl Toxicol 1989 9 39 46 2926095
14. Dosimetry modeling of inhaled formaldehyde: comparisons of local flux predictions in the rat, monkey, and human nasal passages. JS Kimbell RP Subramaniam EA Gross PM Schlosser KT Morgan, Toxicol Sci 2001 64 100 110 11606806
15. Histological changes in the nasal mucosa in persons occupationally exposed to formaldehyde alone and in combination with wood dust. M Holmstrom B Wilhelmsson H Hellquist G Rosen, Acta Otolaryngol 1989 107 120 129 2929309 (Pubitemid 19035862)
16. Work in the metal industry and nasopharyngeal cancer mortality among formaldehyde-exposed workers. GM Marsh AO Youk JM Buchanich S Erdal NA Esmen, Regul Toxicol Pharmacol 2007 48 308 319 17544557
17. Mis-specified and non-robust mortality risk models for nasopharyngeal cancer in the National Cancer Institute formaldehyde worker cohort study. GM Marsh AO Youk P Morfeld, Regul Toxicol Pharmacol 2007 47 59 67 17000042
18. Formaldehyde and cancer risk: a quantitative review of cohort studies through 2006. C Bosetti JK McLaughlin RE Tarone E Pira C La Vecchia, Ann Oncol 2008 19 29 43 17897961
19. The mammalian alcohol dehydrogenases interact in several metabolic pathways. JO Hoog P Stromberg JJ Hedberg WJ Griffiths, Chem Biol Interact 2003 144 175 181
20. S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. DE Jensen GK Belka GC Du Bois, Biochem J 1998 331 659 668 9531510
21. Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase. M Koivusalo M Baumann L Uotila, FEES Lett 1989 257 105 109
22. Medium- and short-chain dehydrogenase/reductase gene and protein families: Dual functions of alcohol dehydrogenase 3: implications with focus on formaldehyde dehydrogenase and S-nitrosoglutathione reductase activities. CA Staab M Hellgren JO Hoog, Cell Mol Life Sci 2008 65 3950 3960 19011746
23. Formaldehyde dehydrogenase from human liver. Purification, properties, and evidence for the formation of glutathione thiol esters by the enzyme. L Uotila M Koivusalo, J Biol Chem 1974 249 7653 7663 4373474
24. The ontogeny, distribution, and regulation of alcohol dehydrogenase 3: implications for pulmonary physiology. CM Thompson B Sonawane RC Grafstrom, Drug Metab Dispos 2009 37 1565 1571 19460944
25. Protein S-nitrosylation: purview and parameters. DT Hess A Matsumoto SO Kim HE Marshall JS Stamler, Nat Rev Mol Cell Biol 2005 6 150 166 15688001
26. S-nitrosothiols modulate G protein-coupled receptor signaling in a reversible and highly receptor-specific manner. T Kokkola JR Savinainen KS Monkkonen MD Retamal JT Laitinen, BMC Cell Biol 2005 6 21 15850493
27. Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. EJ Whalen MW Foster A Matsumoto K Ozawa JD Violin LG Que CD Nelson M Benhar JR Keys HA Rockman, et al. Cell 2007 129 511 522 17482545
28. A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication. P Wang L Day J Dheekollu PM Lieberman, J Virol 2005 79 13298 13309 16227252
29. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. JB Mannick K Asano K Izumi E Kieff JS Stamler, Cell 1994 79 1137 1146 7528106
30. Fas-induced caspase denitrosylation. JB Mannick A Hausladen L Liu DT Hess M Zeng QX Miao LS Kane AJ Gow JS Stamler, Science 1999 284 651 654 10213689
31. Nitric oxide-mediated inhibition of Hdm2-p53 binding. CM Schonhoff MC Daou SN Jones CA Schiffer AH Ross, Biochemistry 2002 41 13570 13574 12427017
32. S-nitrosylation: physiological regulation of NF-kappaB. HE Marshall DT Hess JS Stamler, Proc Natl Acad Sci USA 2004 101 8841 8842 15187230
33. S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide. M Colasanti T Persichini G Venturini P Ascenzi, IUBMB Life 1999 48 25 31 10791912
34. Nitrosation and oxidation in the regulation of gene expression. HE Marshall K Merchant JS Stamler, FASEBJ 2000 14 1889 1900
35. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. D Yao Z Gu T Nakamura ZQ Shi Y Ma B Gaston LA Palmer EM Rockenstein Z Zhang E Masliah, et al. Proc Natl Acad Sci USA 2004 101 10810 10814 15252205
36. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. KK Chung B Thomas X Li O Pletnikova JC Troncoso L Marsh VL Dawson TM Dawson, Science 2004 304 1328 1331 15105460
37. S-nitrosothiol depletion in amyotrophic lateral sclerosis. CM Schonhoff M Matsuoka H Tummala MA Johnson AG Estevez R Wu A Kamaid KC Ricart Y Hashimoto B Gaston, et al. Proc Natl Acad Sci USA 2006 103 2404 2409 16461917
38. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. R Pannu I Singh, Neurochem Int 2006 49 170 182 16765486
39. Endogenous S-nitrosothiols protect against myocardial injury. B Lima GK Lam L Xie DL Diesen N Villamizar J Nienaber E Messina D Bowles CD Kontos JM Hare, et al. Proc Natl Acad Sci USA 2009 106 6297 302 19325130
40. S-nitrosothiol signaling in respiratory biology. B Gaston D Singel A Doctor JS Stamler, Am J Respir Crit Care Med 2006 173 1186 1193 16528016
41. SNOR and wheeze: the asthma enzyme? EM Henderson B Gaston, Trends Mol Med 2005 11 481 484 16214416
42. Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma. H Wu I Romieu JJ Sienra-Monge B Estela Del Rio-Navarro DM Anderson CA Jenchura H Li M Ramirez-Aguilar I Del Carmen Lara-Sanchez SJ London, J Allergy Clin Immunol 2007 120 322 328 17543375
43. Genetic variants of GSNOR and ADRB2 influence response to albuterol in African-American children with severe asthma. PE Moore KK Ryckman SM Williams N Patel ML Summar JR Sheller, Pediatr Pulmonol 2009 44 649 654 19514054
44. Mechanistic considerations for formaldehyde-induced bronchoconstriction involving S-nitrosoglutathione reductase. CM Thompson RC Grafstrom, J Toxicol Environ Health A 2008 71 244 248 18097950
45. Mechanistic and dose considerations for supporting adverse pulmonary physiology in response to formaldehyde. CM Thompson RP Subramaniam RC Grafstrom, Toxicol Appl Pharmacol 2008 233 355 359 18851987
46. Nitric oxide modulates HIV-1 replication. JB Mannick JS Stamler E Teng N Simpson J Lawrence J Jordan RW Finberg, J Acquir Immune Defic Syndr 1999 22 1 9 10534141
47. Principles of Virology. SJ Flint LW Enquist VR Racaniello AM Skalka, Molecular Biology Washington, DC: ASM Press, edition Third 2009 I
48. The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies. NP Dantuma MG Masucci, Semin Cancer Biol 2003 13 69 76 12507558
49. Epstein-Barr virus: induction and control of cell transformation. R Dolcetti MG Masucci, J Cell Physiol 2003 196 207 218 12811813
50. Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system. MG Masucci, Oncogene 2004 23 2107 2115 15021898
51. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. H Zheng LL Li DS Hu XY Deng Y Cao, Cell Mol Immunol 2007 4 185 196 17601372
52. Is the Epstein-Barr virus EBNA-1 protein an oncogen? TF Schulz S Cordes, Proc Natl Acad Sci USA 2009 106 2091 2092 19211802
53. Effect of arginine-deflcient media on the herpes-type virus associated with cultured Burkitt tumor cells. W Henle G Henle, J Virol 1968 2 182 191 4316020
54. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. HM Lander JS Ogiste SF Pearce R Levi A Novogrodsky, J Biol Chem 1995 270 7017 7020 7706235
55. Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines. X Gao M Tajima T Sairenji, Virology 1999 258 375 381 10366574
56. EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines. SC Tsai SJ Lin PW Chen WY Luo TH Yeh HW Wang CJ Chen CH Tsai, Blood 2009 114 109 118 19417211
57. S-Nitrosoglutathione Reductase - An Important Regulator in Human Asthma. LG Que Z Yang JS Stamler NL Lugogo M Kraft, Am J Respir Crit Care Med 2009 180 226 231 19395503
58. Protection from experimental asthma by an endogenous bronchodilator. LG Que L Liu Y Yan GS Whitehead SH Gavett DA Schwartz JS Stamler, Science 2005 308 1618 1621 15919956
59. Formaldehyde exposure induces airway inflammation by increasing eosinophil infiltrations through the regulation of reactive oxygen species production. WW Jung EM Kim EH Lee HJ Yun HR Ju MJ Jeong KW Hwang D Sul HS Kang, Environmental Toxicology and Pharmacology 2007 24 174 182
60. Up-regulation of GSNO reductase in mice lungs by formaldehyde inhalation. C Yi K Ke L Xiaohua Y Xu, The 1st International Conference on Bioinformatics and Biomedical Engineering. Wuhan, China 2007 294 297
61. Reduction of S-nitrosoglutathione by alcohol dehydrogenase 3 is facilitated by substrate alcohols via direct cofactor recycling and leads to GSH-controlled formation of glutathione transferase inhibitors. CA Staab J Alander M Brandt J Lengqvist R Morgenstern RC Grafstrom JO Hoog, Biochem J 2008 413 493 504 18412547
62. The Janus face of alcohol dehydrogenase 3. CA Staab J Alander R Morgenstern RC Grafstrom JO Hoog, Chem Biol Interact 2009 178 29 35 19038239
63. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. B Gruhne R Sompallae D Marescotti SA Kamranvar S Gastaldello MG Masucci, Proc Natl Acad Sci USA 2009 106 2313 2318 19139406
64. Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability. SH Pan CC Tai CS Lin WB Hsu SF Chou CC Lai JY Chen HF Tien FY Lee WB Wang, Carcinogenesis 2009 30 366 375 19126642
65. Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells. YR Chen MT Liu YT Chang CC Wu CY Hu JY Chen, J Virol 2008 82 8124 8137 18524825
66. Reactive oxygen signaling and MARK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. F Cerimele T Battle R Lynch DA Frank E Murad C Cohen N Macaron J Sixbey K Smith RS Watnick, et al. Proc Natl Acad Sci USA 2005 102 175 179 15611471
67. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. J Levitskaya A Sharipo A Leonchiks A Ciechanover MG Masucci, Proc Natl Acad Sci USA 1997 94 12616 12621 9356498
68. Aldehyde toxicity and thiol redox state in cell cultures from human aerodigestive tract. RC Grafstrom MI Jernelov JM Dypbukt K Sundquvist L Atzori X Zheng U Mohr KB Adler DI Dungworth CC Harris, et al. Correlations between in vitro and in vivo investigations in inhalation toxicology Washington, DC: ILSI Press 1996 319 336
69. Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. B Metz GF Kersten P Hoogerhout HF Brugghe HA Timmermans A de Jong H Meiring J ten Hove WE Hennink DJ Crommelin, et al. J Biol Chem 2004 279 6235 6243 14638685
70. Toxicity of Methanol and Formaldehyde Towards Saccharomyces cerevisiae as Assessed by DNA Microarray Analysis. D Yasokawa S Murata Y Iwahashi E Kitagawa R Nakagawa T Hashido H Iwahashi, Appl Biochem Biotechnol 2009 19499198
71. Genotoxicity of formaldehyde in cultured human bronchial fibroblasts. RC Grafstrom RD Curren LL Yang CC Harris, Science 1985 228 89 91 3975633
72. Formaldehyde damage to DNA and inhibition of DNA repair in human bronchial cells. RC Grafstrom AJ Fornace Jr H Autrup JF Lechner CC Harris, Science 1983 220 216 218 6828890
73. N-Nitrosodimethylamine. RG Liteplo ME Meek W Windle International Programme on Chemical Safety, Geneva: World Health Organization 2002
74. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. W Godoy RM Albano EG Moraes PR Pinho RA Nunes EH Saito C Higa IM Filho CD Kruel CC Schirmer, et al. Carcinogenesis 2002 23 611 616 11960914
75. Rabbit liver microsomal system: study of interaction with two model N-nitrosamines and their metabolism. M Sulc B Kubickova V Maslova P Hodek, Gen Physiol Biophys 2004 23 423 433 15815077
76. Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro. DF Hou SL Wang ZM He F Yang ZC Chen, Mol Cell Biochem 2007 298 93 100 17146594